Allergan Wants Miotox Patent Invalidated In $600M Botox Row
Allergan Inc. on Monday slapped Miotox LLC with counterclaims alleging one of its patents for Botox used to treat migraine headaches is invalid and that it isn't infringing other patents, after...To view the full article, register now.
Already a subscriber? Click here to view full article